Pfizer (PFE) Tops Q1 EPS by 25c; reaffirms guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.72 -1.44%
Revenue Growth %: -1.8%
Financial Fact:
Discontinued operations--net of tax: 0
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: -1.8%
Financial Fact:
Discontinued operations--net of tax: 0
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q1 EPS of $1.23, $0.25 better than the analyst estimate of $0.98. Revenue for the quarter came in at $18.3 billion versus the consensus estimate of $16.64 billion.
GUIDANCE:
Pfizer sees FY2023 EPS of $3.25-$3.45, versus the consensus of $3.36. Pfizer sees FY2023 revenue of $67-71 billion, versus the consensus of $68.67 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- BofA lists top 5 themes driving next $1tn in incremental semi sales
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
